Skip to main content
. 2010 Jan 19;107(8):3305–3310. doi: 10.1073/pnas.0905444107

Fig. 3.

Fig. 3.

In vivo QD fluorescence—live versus devitalized hMSCs study. Femoral bone defects were treated by delivery of scaffolds containing either 3E6 or 6E6 QD-loaded live hMSCs, 3E6 or 6E6 QD-loaded devitalized hMSCs, or 6E6 QD-loaded HEK cells, with contralateral defects receiving acellular scaffolds only. Ten days later, all defects displayed a clear fluorescent signal.